Infection of purified nuclei by adeno-associated virus 2

被引:69
作者
Hansen, J
Qing, K
Srivastava, A [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA
[4] Walther Canc Inst, Indianapolis, IN 46202 USA
关键词
AAV; trafficking; uncoating; nucleus; nuclear pore complex; DNA synthesis;
D O I
10.1006/mthe.2001.0457
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Adeno-associated virus 2 (AAV), a nonpathogenic human parvovirus, requires co-infection with a helper virus for its optimal replication. Although AAV possesses a broad host range, certain cell types lack the machinery necessary for efficient entry into the cell and intracellular trafficking of AAV into the nucleus, where the viral second-strand DNA synthesis must occur before gene expression. We have demonstrated that in less-permissive mouse fibroblasts, the virus fails to transport to the nucleus due to altered endocytic processing. However, relatively little is known about the intracellular site of viral uncoating and transport of the virion across the nuclear envelope. Here, we provide evidence that AAV can efficiently enter intact nuclei purified from both permissive and less-permissive cell types. Furthermore, entry into the nucleus is time- and temperature re-de pendent, but is not saturable and seems to occur independently of the nuclear pore complex. We also demonstrate that purified nuclei contain all of the machinery necessary for uncoating and viral second-strand DNA synthesis even in the absence of a helper virus. These studies provide new insights into the basic biology of AAV and may also have implications for the optimal use of AAV vectors in human gene therapy.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 27 条
[1]   Selective and rapid uptake of adeno-associated virus type 2 in brain [J].
Bartlett, JS ;
Samulski, RJ ;
McCown, TJ .
HUMAN GENE THERAPY, 1998, 9 (08) :1181-1186
[2]   Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors [J].
Bartlett, JS ;
Wilcher, R ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2777-2785
[3]  
Berns K I, 1979, Adv Virus Res, V25, P407, DOI 10.1016/S0065-3527(08)60574-6
[4]  
Berns KI, 1996, CURR TOP MICROBIOL, V218, P1
[5]   IDENTIFICATION AND CHARACTERIZATION OF A NUCLEAR-PORE COMPLEX PROTEIN [J].
DAVIS, LI ;
BLOBEL, G .
CELL, 1986, 45 (05) :699-709
[6]   Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus [J].
Duan, DS ;
Yue, YP ;
Yan, ZY ;
Yang, JS ;
Engelhardt, JF .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1573-1587
[7]   INHIBITION OF INVITRO NUCLEAR TRANSPORT BY A LECTIN THAT BINDS TO NUCLEAR-PORES [J].
FINLAY, DR ;
NEWMEYER, DD ;
PRICE, TM ;
FORBES, DJ .
JOURNAL OF CELL BIOLOGY, 1987, 104 (02) :189-200
[8]  
FLOTTE TR, 1995, GENE THER, V2, P357
[9]   DEPLETION OF CALCIUM FROM THE LUMEN OF ENDOPLASMIC-RETICULUM REVERSIBLY INHIBITS PASSIVE DIFFUSION AND SIGNAL-MEDIATED TRANSPORT INTO THE NUCLEUS [J].
GREBER, UF ;
GERACE, L .
JOURNAL OF CELL BIOLOGY, 1995, 128 (1-2) :5-14
[10]   Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts [J].
Hansen, J ;
Qing, K ;
Kwon, HJ ;
Mah, C ;
Srivastava, A .
JOURNAL OF VIROLOGY, 2000, 74 (02) :992-996